<p>Use in patients Approximately 60 years age and older: The safety and efficacy in patients greater than 60 years old have not been investigated in placebo-controlled clinical trials. The elderly are more likely to have adverse reactions to sympathomimetic amines.<br />
<br />
Use in children: Safety and effectiveness in children below the age of 12 years have not been established.</p>